Vor Biopharma, Inc. (VOR)
18.03
-1.31
(-6.77%)
USD |
NASDAQ |
Oct 16, 16:00
17.73
-0.30
(-1.66%)
After-Hours: 20:00
Vor Biopharma EPS Diluted (Quarterly) : -1.157 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.157 |
| March 31, 2026 | -5.105 |
| December 31, 2025 | 44.50 |
| September 30, 2025 | -121.63 |
| June 30, 2025 | -251.24 |
| March 31, 2025 | -0.2602 |
| December 31, 2024 | -8.779 |
| September 30, 2024 | -0.4025 |
| June 30, 2024 | -0.4076 |
| March 31, 2024 | -0.4528 |
| December 31, 2023 | -0.3868 |
| September 30, 2023 | -0.4909 |
| June 30, 2023 | -0.4472 |
| March 31, 2023 | -0.4291 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.5142 |
| September 30, 2022 | -0.6258 |
| June 30, 2022 | -0.5785 |
| March 31, 2022 | -0.6097 |
| December 31, 2021 | -0.491 |
| September 30, 2021 | -0.5024 |
| June 30, 2021 | -0.498 |
| March 31, 2021 | -0.4066 |
| December 31, 2020 | -0.4803 |
| September 30, 2020 | -0.3764 |
| June 30, 2020 | -0.2396 |
| March 31, 2020 | -0.2307 |
| December 31, 2019 | -0.1185 |
| September 30, 2019 | -0.1117 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -62.81M |
| Total Expenses (Quarterly) | 62.81M |
| Enterprise Value | 518.59M |
| Earnings Yield | -462.5% |
| Normalized Earnings Yield | -160.93 |